https://www.selleckchem.com/pr....oducts/prt062607-p50
Successful treatment of cats with hypersomatotropism by transsphenoidal hypophysectomy is described in small numbers of cats. To describe the endocrine profile, survival, and remission rates of hypersomatotropism and diabetes mellitus in a cohort of cats with hypersomatotropism that underwent hypophysectomy between 2008 and 2020. Twenty-five client-owned cats with spontaneous hypersomatotropism. Retrospective study. Diagnosis of hypersomatotropism was based on clinical signs, plasma insulin-like growth factor-1 (IGF-1) con